Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile
ANNALS OF ONCOLOGY(2023)
Key words
Nivolumab,Adjuvant therapy,Melanoma,BRAF mutation,Safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined